Shares of H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report) crossed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $22.00 and traded as low as $22.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares changing hands.
H. Lundbeck A/S Price Performance
The company has a market cap of $21.91 billion, a P/E ratio of 25.00 and a beta of 0.68. The firm’s 50-day moving average is $22.00 and its two-hundred day moving average is $22.00. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.15 and a quick ratio of 0.71.
H. Lundbeck A/S Company Profile
H. Lundbeck A/S (OTCMKTS:HLUYY) is a Danish pharmaceutical company headquartered in Copenhagen that specializes in the research, development and commercialization of medicines for disorders of the central nervous system. Founded in 1915 by Hans Lundbeck, the company has built a long-standing focus on neuroscience, concentrating on therapies for psychiatric and neurological conditions rather than broader therapeutic areas.
Lundbeck’s primary activities include discovery and clinical development of novel compounds, regulatory filings, manufacturing and global commercialization of prescription medicines aimed at brain health.
Further Reading
- Five stocks we like better than H. Lundbeck A/S
- System Upgrade: First Internet Bancorp Options Surge
- AI Security Breaches Raise New Risks for Microsoft and Amazon’s Agent Push
- The AI Chip Blockade Is Creating a Shadow Market
- Grab Holdings Stock Forms Bottom After Strong Beat-and-Raise Quarter
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.
